Reproducibility of the peritoneal regression grading score for assessment of response to therapy in peritoneal metastasis.
Fiche publication
Date publication
juin 2019
Journal
Histopathology
Auteurs
Membres identifiés du Cancéropôle Est :
Pr BIBEAU Frédéric
Tous les auteurs :
Solass W, Sempoux C, Carr NJ, Bibeau F, Neureiter D, Jäger T, Di Caterino T, Brunel C, Klieser E, Fristrup CW, Mortensen MB, Detlefsen S
Lien Pubmed
Résumé
The four-tiered peritoneal regression grading score (PRGS) assesses the response to chemotherapy in peritoneal metastasis (PM). The PRGS is used, for example, to assess the response to pressurised intraperitoneal aerosol chemotherapy (PIPAC). However, the reproducibility of the PRGS is currently unknown. We aimed to evaluate the inter- and intraobserver variability of the PRGS.
Mots clés
colorectal cancer, gastric cancer, interobserver variability, ovarian cancer, pancreatic cancer, peritoneal metastasis, pressurised intraperitoneal aerosol chemotherapy, tumour regression grading
Référence
Histopathology. 2019 Jun;74(7):1014-1024